Lodo, Genentech partner on R&D for microbial-derived therapies

Lodo Therapeutics Corp. (New York, N.Y.) and the Genentech Inc. unit of Roche (SIX:ROG; OTCQB:RHHBY) partnered to discover compounds with Lodo's Metagenomics

Read the full 229 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE